...
首页> 外文期刊>Taiwanese journal of obstetrics and gynecology >Factors influencing the abortion interval of second trimester pregnancy termination using misoprostol
【24h】

Factors influencing the abortion interval of second trimester pregnancy termination using misoprostol

机译:影响米索前列醇终止中期妊娠的流产间隔的因素

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives To determine the factors influencing the abortion interval (AI) for medical termination of second-trimester pregnancy using misoprostol. Materials and Methods All patients who were admitted for second-trimester pregnancy termination between January 2008 and August 2013 were reviewed. Those who received either 200?μg or 400?μg of priming vaginal misoprostol, followed by 200?μg of misoprostol orally at 6-hour intervals were enrolled. Results In a total of 101 patients, delivery occurred within 24 hours of commencement in 62 patients (61%) and within 48 hours in 84 patients (83%), and the median AI was 16.5 hours. One patient (1%) failed to deliver. The remaining 100 fetuses were delivered successfully, and the median AI was 16.3 hours. Higher parity [hazard ratio (HR)?=?1.28, p ?=?0.04], the presence of intrauterine fetal demise (HR?=?2.66, p ?=?0.003), and the presence of premature preterm rupture of membranes (HR?=?4.51, p ?=?0.003) were associated with shorter AI. Additionally, all women with premature preterm rupture of membranes delivered successfully within 12 hours; higher parity (odds ratio?=?2.12, p ?=?0.01) and lower fetal birth body weight (odds ratio?=?0.992, p ?=?0.01) were associated with successful delivery within 12 hours. There was no significant difference in AI in the groups that received different doses of priming vaginal misoprostol (200?μg vs. 400?μg). Conclusion Higher parity, intrauterine fetal demise, and preterm premature rupture of membranes were associated with shorter AI. The regimen of 200?μg oral misoprostol at 6-hour intervals following a 200?μg or 400?μg priming vaginal dose is feasible and efficacious for second trimester pregnancy termination.
机译:目的确定影响米索前列醇药物终止妊娠中期妊娠的流产间隔(AI)的因素。资料与方法对所有在2008年1月至2013年8月期间中止妊娠的患者进行了回顾。那些接受200?μg或400?μg初次注射的米索前列醇,然后每隔6小时口服200?μg米索前列醇的患者入选。结果共有101例患者,其中62例(61%)在开始24小时内分娩,84例(83%)在48小时内分娩,中位AI为16.5小时。 1名患者(1%)无法分娩。其余100胎成功分娩,中位AI为16.3小时。较高的均等性[危险比(HR)≥1.28,p≥0.04],子宫内胎儿死亡的存在(HR≥2.66,p≥0.003),以及早产胎膜早破( HR≥4.51,p≥0.003与较短的AI有关。此外,所有早产胎膜早破的妇女均在12小时内成功分娩;较高的胎次(奇数比≥2.12,p≥0.01)和较低的胎儿出生体重(奇数比= 0.992,p≥0.01)与成功在12小时内分娩有关。接受不同剂量的阴道米索前列醇(200?μgvs. 400?μg)的各组的AI值无显着差异。结论较高的胎次,宫内胎儿死亡和胎膜早破与AI缩短有关。初次阴道剂量为200?μg或400?μg后,每隔6小时服用200μg口服米索前列醇的方案是可行的,对终止中期妊娠有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号